top of page

Lormalzi Concentrate for Solution for Infusion 350mg/20mL

Product details

Registration number: SIN17201P

Classification: Prescription Only

Active ingredients: Donanemab

Strength: 350mg/20mL

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: DKSH SINGAPORE PTE. LTD.

ATC code: N06DX05

HSA approval date: 11 March 2025

Manufacturer(s): Lilly France

Manufacturing country/countries: FRANCE

What are the HSA registration number and classification for Lormalzi Concentrate for Solution for Infusion 350mg/20mL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17201P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Lormalzi Concentrate for Solution for Infusion 350mg/20mL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Donanemab

Strength: 350mg/20mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Lormalzi Concentrate for Solution for Infusion 350mg/20mL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for Lormalzi Concentrate for Solution for Infusion 350mg/20mL?

According to the HSA dataset updated 7 August 2026:

Registrant: DKSH SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Lormalzi Concentrate for Solution for Infusion 350mg/20mL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Lilly France

Manufacturing country/countries: FRANCE

Source for this answer

Where can I look up Lormalzi Concentrate for Solution for Infusion 350mg/20mL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17201P or the exact product name Lormalzi Concentrate for Solution for Infusion 350mg/20mL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Lormalzi Concentrate for Solution for Infusion 350mg/20mL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Lormalzi Concentrate for Solution for Infusion 350mg/20mL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17201P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page